About
Technology
Issues
FAQ
Links
Official Page
First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced
KRAS
G12C
Solid Tumors (KRYSTAL-1)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.